NOTE 6 – SHARE-BASED PAYMENTS TO VENDORS

In the fourth quarter of 2023, the Company entered into a number of agreements with vendors pursuant to which the Company made grants of a total of 5,800 share of common stock with grant date fair values ranging from $30.00 to $103.60 and cash payments. These contracts had four to six-month terms with various contractual vesting periods. The cash payments were expensed over the service period and the equity components were expensed consistent with the various contractual vesting periods. The Company recorded general and administrative expenses of $0 and $76,600 for the years ended December 31, 2025 and 2024, respectively.

In the first quarter of 2024, the Company entered into a number of agreements with consultants to provide investor relations services for four-month terms. The cash payments were expensed over the service period and the equity components were expensed consistent with the various contractual vesting periods. Per the agreements, the Company issued a total of 6,000 shares of common stock evenly over the four-month service period with grant date fair values ranging from $37.40 to $96.20. The Company recorded general and administrative expenses of $0 and $329,700 for the years ended December 31, 2025 and 2024, respectively.

In the second quarter of 2024, the Company entered into a number of agreements with consultants to provide investor relation services for six-month terms. The cash payments were expensed over the service period and the equity components were expensed consistent with the various contractual vesting periods. Per the agreements, the Company issued a total of 7,800 shares of common stock evenly over the six-month service period with grant date fair values ranging from $36.00 to $48.00. The Company recorded general and administrative expenses of $0 and $312,600 for the years ended December 31, 2025 and 2024, respectively.

In the fourth quarter of 2024, the Company entered into a number of agreements with vendors pursuant to which the Company made grants of a total of 3,800 shares of common stock with grant date fair values ranging from $8.12 to $41.60. These contracts had six to twelve-months terms with various contractual vesting periods and were expensed consistently with the various contractual vesting periods. The Company recorded general and administrative expenses of $16,559 and $93,780 for the years ended December 31, 2025 and 2024, respectively.

In addition, in the fourth quarter of 2024, the Company entered into a 12-month agreement with a vendor pursuant to which the Company made quarterly grants equal to $21,000 worth of common stock and certain cash payments. The share-based payments were expensed consistently over the contractual vesting period. The Company granted total of 7,660 shares of common stock with grant date fair values ranging from $6.52 to $37.60. The Company recorded general and administrative expenses of $63,000 and $21,000 for the years ended December 31, 2025 and 2024, respectively. This agreement was extended in the fourth quarter of 2025 for additional 12-month term and pursuant to the agreement, the Company issued 5,426 shares of common stock with grant date fair value of $3.87 and recorded general and administrative expense of $21,000 for the year ended December 31, 2025.

In the first quarter of 2025, the Company entered into an agreement with a vendor to provide investor relations services for a six-month term. Pursuant to the agreement, the Company issued a total of 12,000 shares of common stock and made a certain cash payment. The cash payment and the equity components were expensed consistently over the contractual vesting period. The Company issued 12,000 shares of common stock with grant date fair values ranging from $6.80 to $16.20 and recorded general and administrative expense of $124,280 for the year ended December 31, 2025.

In the second quarter of 2025, the Company entered into an agreement with a vendor to provide investor relations services for a six-month term. Pursuant to the agreement, the Company issued 2,300 shares of common stock with a grant date fair value of $7.60 and recorded general and administrative expenses of $17,480 for the year ended December 31, 2025. This agreement was amended in the third quarter of 2025 for an additional six-month term and pursuant to the agreement, the Company will make quarterly grants equal to $20,000 worth of common stock and certain cash payments. The cash payments and the equity components will be expensed consistently over the contractual vesting

period. Pursuant to the agreement, the Company issued 19,316 shares of common stock with grant date fair values ranging from $3.37 to $4.95 and recorded general and administrative expenses of $80,000 for the year ended December 31, 2025.